China channel feed – Endpoints News

China channel feed

Manufacturing experts at Hangzhou Just Biotherapeutics bank $35M for stealthy R&D in China and the US

7 years ago

Eyeing NDA for its diabetes drug, Hua Medicine knocks at HKEX's door with an IPO application

7 years ago

Prepping a drug launch, Zai Lab poaches AstraZeneca’s top cancer drug sales exec in China

7 years ago

With competition on its heels, Blueprint takes three cancer drugs to China

7 years ago

After sinking $300M into SF fund last year, Hong Kong conglomerate launches $100M arm in Shanghai

7 years ago

CRI report tracks explosive growth of cell therapies in the global pipeline, as China researchers muscle toward the front

8 years ago

Grail hauls in monster $300M round from Chinese investors amid rumors about Hong Kong IPO

8 years ago

China's CStone bags $260M Series B for ambitious I/O work, expanding its list of marquee investors

8 years ago

Set to be the first pre-revenue biotech to list in Hong Kong, Ascletis lays out priorities in IPO application

8 years ago

Ahead of Hong Kong listing changes, WuXi preps for a biotech boom with a new R&D center in Shanghai

8 years ago

Forget Nasdaq. China’s biotechs with blockbuster IPO dreams are switching focus to Hong Kong

8 years ago

Hong Kong clears way for pre-revenue biotech IPOs, plans to accept listing applications by May

8 years ago

Endpoints' China coverage is getting deeper. Announcing our partnership with PharmCube, the leading Chinese biopharma data provider

8 years ago

Publisher's note

As gene editing explodes, a new report from Goldman says Chinese groups are seizing the lead on CRISPR and CAR-T studies

8 years ago

After a makeover and hiring spree, China's drug agency is romping and stomping on new reviews and approvals

8 years ago

Chinese oncology startup Adagene closes $50M Series C led by Sequoia Capital

8 years ago

China's biotech pipeline is brimming with PD-1/L1 checkpoints. Are they really needed?

8 years ago

Shakeup at China FDA after chief vaults to the helm of a regulatory umbrella group, new agency head named

8 years ago

China stocks the new trend? Loncar launches index

8 years ago

Bye CFDA: China's drug regulator to take new shape in major government restructuring

8 years ago

Hua Medicine plans to join trendy Hong Kong IPO club, pitching an offering of up to $400M -- reports

8 years ago

Juno, WuXi JV gets a $90M round as China’s CAR-T pioneers fly high with fresh cash

8 years ago

Oxford Vacmedix moves cancer vaccines forward with $12.5M from South Korea, China

8 years ago

Chinese medicine player Tasly considers Hong Kong IPO for its biotech arm: report

8 years ago

First page Previous page 24 25 262728 29 Next page Last page